Company

Cybin, Inc.

Headquarters: Toronto, ON, Canada

Employees: 38

NEO: CYBN +1.76%

Market Cap

C$273.5 Million

CAD as of July 1, 2024

US$199.1 Million

Market Cap History

Cybin, Inc. market capitalization over time

Evolution of Cybin, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cybin, Inc.

Detailed Description

Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Cybin, Inc. has the following listings and related stock indices.


Stock: NEO: CYBN wb_incandescent

Stock: FSX: R7E1 wb_incandescent

Stock: NYSE: CYBN wb_incandescent

Details

Headquarters:

100 King Street West

Suite 5600

Toronto, ON M5X 1C9

Canada

Phone: 908 764 8385